Overall, the current meta-analysis included 14 studies with 2712 cases of gynecologic cancer and 3638 controls and observed a significant association between the hOGG1 Ser326Cys polymorphism and overall gynecologic cancer susceptibility. Here, OGG1 is linked to female reproductive organ cancer.